News
Aktionäre von Cembra stimmen allen Anträgen des Verwaltungsrats zu
Hudson Awarded Ten-Year Contract Extension At Ontario International Airport
Mobimo Holding AG: Mobimo gibt die Bedingungen der Kapitalerhöhung bekannt
Quartalsabschluss der Glarner Kantonalbank per 31.3.2022
Phoenix Mecano steigert Profitabilität erneut überproportional
CALIDA GROUP schliesst Verkauf der MILLET MOUNTAIN GROUP erfolgreich ab
Gurit meldet einen Nettoumsatz von CHF 107,7 Millionen im ersten Quartal 2022
Solarpark Sembach steigert Profitabilität mit modularem 11,9-MWh-LeBlock-Batteriespeicher - Frequenzregulierung als zusätzlicher Service
BLKB richtet Sponsoring an Nachhaltigkeitskriterien aus
Orascom Development Holding AG: Publikation der Einberufung zur ordentlichen Generalversammlung 2022
Vifor Pharma supports Iron Deficiency Day 2021: Call to action for early iron deficiency diagnosis
Already for the seventh consecutive year of Iron Deficiency Day, Vifor Pharma is supporting a growing international alliance including the Heart Failure Policy Network, European Kidney Health
Vifor Pharma to spearhead development of vascular calcification field, through acquisition of Sanifit Therapeutics and Inositec AG
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Pharma has announced the acquisition of Sanifit Therapeutics, a Spanish clinical-stage cardio-renal biopharmaceutical company
VFMCRP receives positive CHMP opinion for Tavneos® for the treatment of ANCA-associated vasculitis
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced that the European Medicines Agency’s (EMA) CHMP has recommended
Vifor Pharma and Angion report topline results from phase-III registration trial of ANG-3777 in kidney transplant patients at risk for delayed graft function
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211026006150/en/
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor
Kudelski IoT Expands Security Trainings to North America to Help Companies Meet Growing Security Regulatory Requirements
Kudelski IoT, a division of the Kudelski Group (SIX: KUD.S), the world leader in digital security and IoT solutions, today announced the expansion of its successful IoT Security Workshops to
ABB: Q3 2021 Results
ABB (SWX:ABBN):
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211020006194/en/
KEY FIGURES
Vifor Pharma announces changes to its Executive Committee
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Pharma Group today announced changes to its Executive Committee as current members Lee Heeson, President International, and
Kudelski IoT and Idneo Enable Secure and Simple Accessibility Solutions to Electric Vehicles and Mobility-As-A-Service Clients
Kudelski IoT, a division of the Kudelski Group (SIX: KUD.S), the world leader in digital security and IoT solutions, and Idneo Technologies, a leading engineering service company with deep
ABB Launches the World’s Fastest Electric Car Charger
ABB is today launching an innovative all-in-one Electric Vehicle (EV) charger, which provides the fastest charging experience on the market.
ABB’s new Terra 360 is a modular charger which can
VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced that Japan’s Ministry of Health and Labor Welfare (MHLW) has granted its partner, Kissei Pharmaceutical Co., Ltd., marketing
GeNeuro and Northwestern University Enter Into a Research Collaboration on HERV-W ENV in Long-haul COVID
GeNeuro (Paris:GNRO) (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases, such as multiple sclerosis
Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210915005966/en/
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor
Vifor Pharma’s Ferinject® granted new recommendations in updated 2021 ESC heart failure guidelines
Regulatory News:
Vifor Pharma is pleased to announce that the European Society of Cardiology (ESC) included new recommendations and proposals in the 2021 ESC guidelines for the diagnosis and